Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients

BACKGROUND: Presently, a 50-gene expression model (PAM50) serves as a breast cancer (BC) subtype classifier that is insufficient to distinguish, within each single PAM50-classified subtype, patient subpopulations having different prognosis. There is a pressing need for inexpensive and minimally inva...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankney, J. Astor, Xie, Ling, Wrobel, John A., Wang, Li, Chen, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543675/
https://www.ncbi.nlm.nih.gov/pubmed/31146747
http://dx.doi.org/10.1186/s12920-019-0530-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543675/
https://www.ncbi.nlm.nih.gov/pubmed/31146747
http://dx.doi.org/10.1186/s12920-019-0530-7

Ejemplares similares